OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma
Yi Liao, Hua Xiao, Mengqing Cheng, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 47
Yi Liao, Hua Xiao, Mengqing Cheng, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3474-3474
Open Access | Times Cited: 45
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3474-3474
Open Access | Times Cited: 45
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
Jianming Wei, Ye Zeng, Xibo Gao, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Jianming Wei, Ye Zeng, Xibo Gao, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis
Yi Liao, Guofang Yin, Xue Wang, et al.
Oncology Letters (2019)
Open Access | Times Cited: 43
Yi Liao, Guofang Yin, Xue Wang, et al.
Oncology Letters (2019)
Open Access | Times Cited: 43
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
Huaide Qiu, Yongqiang Li, Shupeng Cheng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 41
Huaide Qiu, Yongqiang Li, Shupeng Cheng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 41
Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis
Conglin Ren, Mingshuang Li, Weibin Du, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 38
Conglin Ren, Mingshuang Li, Weibin Du, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 38
LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma
Fahui Liu, Wanyun Hou, Jiadong Liang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 13, pp. 4039-4048
Open Access | Times Cited: 32
Fahui Liu, Wanyun Hou, Jiadong Liang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 13, pp. 4039-4048
Open Access | Times Cited: 32
BCSCdb: a database of biomarkers of cancer stem cells
Shazia Firdous, Abhirupa Ghosh, Sudipto Saha
Database (2022) Vol. 2022
Open Access | Times Cited: 20
Shazia Firdous, Abhirupa Ghosh, Sudipto Saha
Database (2022) Vol. 2022
Open Access | Times Cited: 20
The Value of the Stemness Index in Ovarian Cancer Prognosis
Hongjun Yuan, Qian Yu, Jianyu Pang, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 993-993
Open Access | Times Cited: 19
Hongjun Yuan, Qian Yu, Jianyu Pang, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 993-993
Open Access | Times Cited: 19
A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts
Jiaxing Lin, Jieping Yang, Xiao Xu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Jiaxing Lin, Jieping Yang, Xiao Xu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Endogenous tumor microenvironment-responsive multifunctional nanoplatforms for precision cancer theranostics
Cong Wang, Shuizi Ding, Shaoxiong Wang, et al.
Coordination Chemistry Reviews (2020) Vol. 426, pp. 213529-213529
Closed Access | Times Cited: 29
Cong Wang, Shuizi Ding, Shaoxiong Wang, et al.
Coordination Chemistry Reviews (2020) Vol. 426, pp. 213529-213529
Closed Access | Times Cited: 29
Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
Wei Chen, Mingkai Chen, Wenying Deng, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 21
Wei Chen, Mingkai Chen, Wenying Deng, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 21
Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13
Jiangtao Wang, Weiwei Shi, Yandong Miao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6286-6304
Open Access | Times Cited: 19
Jiangtao Wang, Weiwei Shi, Yandong Miao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6286-6304
Open Access | Times Cited: 19
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer
Teng Zhang, Jun Li, Junyong Dai, et al.
Cancer Genetics (2023) Vol. 276-277, pp. 48-59
Closed Access | Times Cited: 7
Teng Zhang, Jun Li, Junyong Dai, et al.
Cancer Genetics (2023) Vol. 276-277, pp. 48-59
Closed Access | Times Cited: 7
Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index
Rihan Wu, Ru Ma, Xiaojun Duan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Rihan Wu, Ru Ma, Xiaojun Duan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
High expression of SPAG 5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β‐catenin signalling
Jue Jiang, Juan Wang, Xin He, et al.
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 46, Iss. 6, pp. 597-606
Closed Access | Times Cited: 21
Jue Jiang, Juan Wang, Xin He, et al.
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 46, Iss. 6, pp. 597-606
Closed Access | Times Cited: 21
Prognostic and clinicopathological value of BUB1B expression in patients with lung adenocarcinoma: a meta-analysis
Jie Chen, Yi Liao, Xianming Fan
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 7, pp. 795-803
Closed Access | Times Cited: 16
Jie Chen, Yi Liao, Xianming Fan
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 7, pp. 795-803
Closed Access | Times Cited: 16
Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and lipidome
Peng Cao, Sanlan Wu, Wei Guo, et al.
Metabolomics (2021) Vol. 17, Iss. 11
Closed Access | Times Cited: 16
Peng Cao, Sanlan Wu, Wei Guo, et al.
Metabolomics (2021) Vol. 17, Iss. 11
Closed Access | Times Cited: 16
Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma
Jingwei Ke, Jie Chen, Xin Liu
Animal Cells and Systems (2022) Vol. 26, Iss. 2, pp. 52-61
Open Access | Times Cited: 11
Jingwei Ke, Jie Chen, Xin Liu
Animal Cells and Systems (2022) Vol. 26, Iss. 2, pp. 52-61
Open Access | Times Cited: 11
Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma
Yinhe Feng, Xingyu Xiong, Yubin Wang, et al.
Lung (2022) Vol. 200, Iss. 3, pp. 381-392
Closed Access | Times Cited: 10
Yinhe Feng, Xingyu Xiong, Yubin Wang, et al.
Lung (2022) Vol. 200, Iss. 3, pp. 381-392
Closed Access | Times Cited: 10
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
Jing Zhen, Jingying Pan, Xuanrui Zhou, et al.
Aging (2023)
Open Access | Times Cited: 6
Jing Zhen, Jingying Pan, Xuanrui Zhou, et al.
Aging (2023)
Open Access | Times Cited: 6
Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma
Peng Kun, Ning Wang, Qingyuan Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13793-13810
Closed Access | Times Cited: 6
Peng Kun, Ning Wang, Qingyuan Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13793-13810
Closed Access | Times Cited: 6
Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma
Yishuai Li, Longyu Zhu, Hao Ran, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 9, pp. 4349-4362
Open Access | Times Cited: 13
Yishuai Li, Longyu Zhu, Hao Ran, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 9, pp. 4349-4362
Open Access | Times Cited: 13
Characterization of a prognostic model for lung squamous cell carcinoma based on eight stemness index-related genes
Wenfa Jiang, Ning Xie, Chenyang Xu
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Wenfa Jiang, Ning Xie, Chenyang Xu
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Genomic Integrity Safeguards Self-Renewal in Embryonic Stem Cells
Jie Su, Dandan Zhu, Zijun Huo, et al.
Cell Reports (2019) Vol. 28, Iss. 6, pp. 1400-1409.e4
Open Access | Times Cited: 15
Jie Su, Dandan Zhu, Zijun Huo, et al.
Cell Reports (2019) Vol. 28, Iss. 6, pp. 1400-1409.e4
Open Access | Times Cited: 15
Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma
Yujiao Wang, XinXing Zhang, Xiaosong Dai, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 10, pp. 1161-1170
Closed Access | Times Cited: 12
Yujiao Wang, XinXing Zhang, Xiaosong Dai, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 10, pp. 1161-1170
Closed Access | Times Cited: 12
